Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6431]

ASTRO: Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer

ASTRO: Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer

New gene research helps pinpoint prostate cancer risk

New gene research helps pinpoint prostate cancer risk

$ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL$

ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL

ASTRO: Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments

ASTRO: Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments

ASTRO: NSCLC patients who never smoked or who quit smoking have lower risk of developing secondary cancers

ASTRO: NSCLC patients who never smoked or who quit smoking have lower risk of developing secondary cancers

Lactation linked to reduced oestrogen receptor-negative, triple-negative breast cancer risk

Lactation linked to reduced oestrogen receptor-negative, triple-negative breast cancer risk

Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?

Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?

Patients with head and neck cancers resistant to cetuximab may benefit from an investigational drug

Patients with head and neck cancers resistant to cetuximab may benefit from an investigational drug

Clinical development programme of tecemotide as a monotherapy in stage III non-small cell lung cancer discontinued

Clinical development programme of tecemotide as a monotherapy in stage III non-small cell lung cancer discontinued

International study identifies new genetic variants indicating risk for prostate cancer

International study identifies new genetic variants indicating risk for prostate cancer

More from ecancer